In vitro effects of glycyrrhetinic acid and hyaluronic acid on the growth of vulvovaginal Candida albicans and other yeasts

In vitro effects of glycyrrhetinic acid and hyaluronic acid on the growth of vulvovaginal Candida albicans and other yeasts

Aims. The present study aimed to test the in vitro activity against Candida albicans and non-albicans strains of 18-β glycyrrhetinic acid (18-β GA) and hyaluronic acid (HA), both alone and in combination. This antimicrobial activity was assessed using the National Committee for Clinical Laboratory S...

Full description

Bibliographic Details
Main Authors:	Martina Stevan, Eleonora Fusato, Decio Armanini, Giulio Bertoloni, Francesco De Seta, Christian Leli, Mario Rassu
Format:	Article
Language:	English
Published:	PAGEPress Publications 2017-12-01
Series:	Microbiologia Medica
Subjects:	18-β glycyrrhetinic acid hyaluronic acid, Candida albicans Candida non-albicans recurrent vulvovaginal candidiasis.
Online Access:	http://www.pagepressjournals.org/index.php/mm/article/view/6974

Similar Items

Características clínicas de vulvovaginitis por cándida albicans en mujeres en edad reproductiva
by: Nathaly Lisseth Barraza Guimarrea, et al.
Published: (2019-07-01)

Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran
by: Seddigheh Esmaeilzadeh, et al.
Published: (2009-08-01)

Investigation of the Effect of Gold Nanoparticles on Vital Factors of Isolated Candida albicans in Patients with Vulvovaginal Candidiasis In Vitro
by: J Alipoor, et al.
Published: (2015-06-01)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
by: Ali Zarei Mahmoudabadi, et al.
Published: (2013-03-01)

pH-Dependant Antifungal Activity of Valproic Acid against the Human Fungal Pathogen Candida albicans
by: Julien Chaillot, et al.
Published: (2017-10-01)

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis
by: Mei Gao, et al.
Published: (2016-11-01)

Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method
by: Baghdad Science Journal
Published: (2016-06-01)

Determination of prevalancy and Species of vulvovaginal Candidiasis and clinical findings corrolation
by: Gharaei A, et al.
Published: (2015-06-01)

Vulvovaginal candidiasis therapy in reproductive age women
by: Т. Г. Романенко, et al.
Published: (2020-10-01)

Candidíase vulvovaginal: fatores predisponentes do hospedeiro e virulência das leveduras Vulvovaginal candidiasis: susceptibility factors of the host and virulence of the yeasts
by: Cassiana Aparecida Álvares, et al.
Published: (2007-10-01)

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
by: V. N. Serov, et al.
Published: (2016-12-01)

Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis
by: Xu Zhang, et al.
Published: (2018-10-01)

Investigation of Presence of SAP3 Virulence Gene in Candida albicans Strains Isolated from Patients with Vulvovaginal Candidiasis
by: Ahmad Jabrodini, et al.
Published: (2018-12-01)

Does alternation of Candida albicans TUP1 gene expression affect the progress of symptomatic recurrent vulvovaginal candidiasis?
by: Mona Ghazanfari, et al.
Published: (2020-06-01)

ALS1 and ALS3 gene expression and biofilm formation in Candida albicans isolated from vulvovaginal candidiasis
by: Shahla Roudbarmohammadi, et al.
Published: (2016-01-01)

Evaluation of esterase and hemolysin activities of different Candida species isolated from vulvovaginitis cases in Lorestan Province, Iran
by: Maryam Noori, et al.
Published: (2017-12-01)

Clinical Candida albicans Vaginal Isolates and a Laboratory Strain Show Divergent Behaviors during Macrophage Interactions
by: Franziska Gerwien, et al.
Published: (2020-08-01)

Characterization of Candida Species Isolated from cases of Vulvovaginitis in women referring to selected gynecological clinics
by: Batol Bonyadpour, et al.
Published: (2016-10-01)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
by: Adane Bitew, et al.
Published: (2018-06-01)

Determination of virulence factors and biofilm formation among isolates of vulvovaginal candidiasis
by: Tapan Majumdar, et al.
Published: (2016-01-01)

Etiologic factors of Candida vulvovaginitis in pregnant women
by: Sousan Mohammadi, et al.
Published: (2020-06-01)

Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests
by: Luciana Basili Dias, et al.
Published: (2011-12-01)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
by: Diletta Rosati, et al.
Published: (2020-01-01)

Study of vulvovaginal candidiasis in symptomatic women of reproductive age group attending tertiary care institute, Haryana province
by: Gulnar K, et al.
Published: (2021-02-01)

Synergistic Antifungal Effect of Fluconazole Combined with ZnO Nanoparticles against Candida albicans Strains from Vaginal Candidiasis
by: Azadeh abedzadeh hajar, et al.
Published: (2020-05-01)

Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era
by: Pâmela Cristina Mastellaro Delvas Zanni, et al.

Effects of depomedroxyprogesterone acetate on the development and maintenance of Candida albicans in the vagina of oophorectomized Wistar rats (Rattus norvegicus)
by: Agenor Storti-Filho, et al.
Published: (2011-03-01)

Comparison of Fluconazole and Clotrimazole in the Treatment of Acute Candida Albicans Vulvovaginitis
by: Fatemeh Bahadori, et al.
Published: (2008-12-01)

Determination of Drug Susceptibility of Candida Strains Isolated From Patients With Recurrent Candida Vulvovaginitis and Investigation of Predisposing Factors of the Disease
by: MH Minooeianhaghighi, et al.
Published: (2017-03-01)

Genotypic Patterns of Secreted Aspartyl Proteinase Gene in Various Candida Species Isolated from Antenatal Women with Vulvovaginal Candidiasis
by: Kanishka Hrishi Das, et al.
Published: (2019-06-01)

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Serotyping of Candida albicans isolated from clinical specimens
by: Maria L. Martinez Batista, et al.
Published: (1990-03-01)

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
by: Amir Arastehfar, et al.
Published: (2021-04-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Oral candidosis by Candida albicans in normal and xerostomic mice Candidose oral por Candida albicans em camundongos normais e xerostômicos
by: Marilda Aparecida Gonçalves Totti, et al.
Published: (2004-09-01)

Identification of Candida species by molecular and mycological methods in pregnant women with vulvovaginal candidiasis
by: Nahid Arefi Lisar, et al.
Published: (2018-03-01)

Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment
by: Matheus Aparecido dos Santos Ramos, et al.
Published: (2016-08-01)

Presença de Candida nas mucosas vaginal e bucal e sua relação com IgA salivar Relationship between Candida in vaginal and oral mucosae and salivary IgA
by: Célia Regina Gonçalves e Silva, et al.
Published: (2008-06-01)

Sistemas líquido-cristalinos como potencial estratégia para administração vaginal de ácido p-cumárico no tratamento de candidíase vulvovaginal /
by: Ferreira, Paula Scanavez
Published: (2020)

Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India
by: Varsha Kumari, et al.
Published: (2013-01-01)